EDGE
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries
  • db-search.svg
    Company Search
  • company-list.svg
    My Watchlists (Beta)
All Updates

All Updates

icon
Filter
Funding
‧
Partnerships
3DBioFibR and PlantForm raise CAD 1.3 million to create dry-spun recombinant human collagen fibers
Bio-based Materials
Jan 18, 2024
This week:
Funding
Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory
Plant-based Meat
Today
Last week:
M&A
Platform Science to acquire Trimble's global transportation telematics business units
Truck Industry Tech
Yesterday
Funding
Whatfix raises USD 100 million in Series E funding to expand business
EdTech: Corporate Learning
Yesterday
Product updates
Sky Mavis launches cross-game onboarding solution
Web3 Ecosystem
Sep 14, 2024
Funding
Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa
Precision Medicine
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Precision Medicine
Sep 13, 2024
Partnerships
Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies
Cell & Gene Therapy
Sep 13, 2024
Product updates
Quandela launches European quantum computer in North America
Quantum Computing
Sep 13, 2024
Partnerships
IonQ achieves high qubit gate fidelity on barium development platform
Quantum Computing
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Clinical Trial Technology
Sep 13, 2024
Bio-based Materials

Bio-based Materials

View industry hub
Jan 18, 2024

3DBioFibR and PlantForm raise CAD 1.3 million to create dry-spun recombinant human collagen fibers

Funding
Partnerships

  • 3DBioFibR Inc, a Halifax-based biomaterials developer, and PlantForm Corporation, a biopharmaceutical firm, have received CAD 1.3 million (~USD 966,000) from Next Generation Manufacturing Canada (NGen) to support one-third of their CAD 3.6 million (~USD 2.76 million) project, with the remaining expenses covered by the companies.

  • The funding will be used to support a project to create the first large-scale dry spinning of recombinant human collagen fibers, which will be integrated into the pharmaceutical and biomedical sectors, among others.

  • PlantForm and 3DBioFibR aim to reproduce natural collagen fibers to match or surpass their natural strength, a significant stride for the biomaterial and tissue engineering field. Presently, 3DBioFibR leads in creating biomaterials for tissue regeneration, whereas PlantForm focuses on the inexpensive production of high-value vaccines and protein-based drugs via the vivoXPRESS plant-based manufacturing system.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.